| Authors: |
Ducimetière L; Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Lucchiari G; Tumor Immunology, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Litscher G; Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Nater M; Tumor Immunology, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Heeb L; Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Nuñez NG; Inflammation Research, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Wyss L; Tumor Immunology, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Burri D; Tumor Immunology, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Vermeer M; Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Gschwend J; Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., Moor AE; Institute of Molecular Cancer Research, University of Zurich, CH-8057 Zurich, Switzerland., Becher B; Inflammation Research, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland., van den Broek M; Tumor Immunology, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland; vandenbroek@immunology.uzh.ch tugues@immunology.uzh.ch., Tugues S; Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, CH-8057 Zurich, Switzerland; vandenbroek@immunology.uzh.ch tugues@immunology.uzh.ch. |
